Birdwatch Note Rating
2025-03-13 02:38:16 UTC - HELPFUL
Rated by Participant: 0A3A85F1ABB42E5F9014A4D51E7D50D426D86025D70077010B9EDE55F21E7408
Participant Details
Original Note:
Both serologic and epidemiologic evidence indicate that vaccine-induced measles immunity appears to be long-term and probably lifelong in most persons. https://www.cdc.gov/vaccines/vpd/mmr/hcp/about.html#:~:text=Both%20serologic%20and%20epidemiologic%20evidence%20indicate%20that%20vaccine%2Dinduced%20measles%20immunity%20appears%20to%20be%20long%2Dterm%20and%20probably%20lifelong%20in%20most%20persons. The measles vaccine is one of those that has the highest benefit/cost ratio. https://pubmed.ncbi.nlm.nih.gov/2516660/#:~:text=one%20of%20those%20that%20has%20the%20highest%20benefit/cost%20ratio%20is%20measles%20immunization
All Note Details